跳至主要内容
临床试验/CTRI/2024/09/074512
CTRI/2024/09/074512尚未招募2 期

Clinical validation of Unani pharmacopoeial formulation Majoon Mussaffi Azam in Busoor(Skin eruptions)

central council for research in Unani medicine1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年10月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
70
试验地点
1
主要终点
The lesion will be evaluated according to its number, size, and associated symptoms. Grading on the basis of the number of lesions will be recorded

研究概览

简要总结

it is a single arm open labelled study in which patients visiting OPD with the complaints of Busoor willing to undergo trial and fulfilling the inclusion criteria will be recruited. after screening the drug will be given orally for30 days.the efficacy and safety will be checked accordindly

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
12.00 Year(s) 至 60.00 Year(s)(—)
性别
Female

入选标准

  • Frequently occurrence of Busoor, with or without association of following features.
  • 1.Humra (Erythema) 2 .Waja (Pain)
  • Hikka (Itching.

排除标准

  • 1 .Patients of Busoor associated with fever.
  • Patients with other inflammatory and suppurated conditions of skin e.g. Abscess, Carbuncle, and Cellulitis.
  • 3.Patients with features of Cellulitis 4.Patients with diabetes mellitus 5.Patients with disease required long term treatment e.g. Metabolic Disorders, specific infectious disease and cancer etc.
  • 6.Pregnancy and lactation.

结局指标

主要结局

The lesion will be evaluated according to its number, size, and associated symptoms. Grading on the basis of the number of lesions will be recorded

时间窗: Baseline,Day 7,Day 14,Day 28

次要结局

未报告次要终点

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr Huma

Regional research institute of unani medicine

研究点 (1)

Loading locations...

相似试验

safety and efficacay of unani formulation Majoon... | 临床试验